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Knowledgeof the choroidal structures in eyes with diabetes and diabetic retinopathy (DR) should 
provide information on the pathogenesis of DR. A prospective study was performed to determine the 
systemic and ocular factors that affect the choroidal structures in eyes with diabetes. Two-hundred 
consecutive diabetic subjects consisted of 160 treatment-naïve patients with different stages of DR and 
40 patients with proliferative DR with prior panretinal photocoagulation (PRP). All underwent blood 
and urine tests and enhanced depth imaging optical coherence tomography (EDI-OCT). The cross-
sectional EDI-OCT images of the subfoveal choroid were binarized to measure the total choroidal area 
(TCA), luminal area, and stromal area. Multivariate regression analyses were performed to determine 
the systemic and ocular factors that were significantly correlated with the choroidal structures. The 
subfoveal choroidal thickness, TCA, luminal area, and stromal area were larger at more advanced 
stage of DR, and smaller in eyes with PRP than those without (P < 0.001). The TCA and stromal area 
were significantly and positively correlated with the degree of albuminuria (P = 0.034, P = 0.025, 
respectively). the choroidal lumen and stroma may increase as the stages of DR progress and decrease 
after PRP. Albuminuria may be associated with the choroidal stromal edema.
Recent studies have shown that the choroid plays an important role in the physiology of the eye and the patho-
genesis of different retinal diseases including diabetic retinopathy (DR)1–5. Because choriocapillaris supplies the 
oxygen and nutrients to the outer retinal layers, impairment of choriocapillaris can cause photoreceptor dysfunc-
tion and death.
The results of studies on choroidal thickness in eyes with diabetes and DR are still contradictory. Several 
studies reported there was a thinning of choroid as the disease progressed1,2, while others reported it thickened 
contrary3 or did not change4,5. One of the reasons for the discrepancies is that there are many potential confound-
ers that can influence the choroidal thickness. These include age, refractive error, axial length, diurnal variations, 
prior ocular treatments including retinal photocoagulation, intravitreal injection of anti-vascular endothelial 
growth factors, intravitreal or subtenon injection of steroids, and intraocular surgeries6–13. In addition, duration 
of diabetes, status of glycemic control, severity of diabetic nephropathy, systemic hypertension, dyslipidemia, 
anemia, and medications to treat these conditions can also influence the choroidal vasculature and stroma14–21. 
Other limitations of previous studies include their retrospective nature and small sample size1,4,5.
There is good evidence for microvascular dropout and narrowing of the choroidal arterioles which are one of 
the characteristic features of the DR that can cause a thinning of choroid22,23. However, it may also be possible that 
increased vascular permeability, another characteristic feature of the DR, can cause a swelling of the choroidal 
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stroma and thickening of the choroid3. Thus, it would be useful to evaluate the vascular and stromal components 
of the choroid separately to understand the pathophysiology of DR.
A method using the binarization of enhanced depth imaging optical coherence tomographic (EDI-OCT) 
images or swept source OCT images can differentiate and quantify the choroidal luminal area and the stromal 
area with high repeatability and reproducibility in normal and diseased eyes8,9,24,25.
Thus, the purpose of this study was to prospectively evaluate the choroidal structures in patients with dia-
betes with and without DR using binarization of EDI-OCT images and to determine the systemic and ocular 
factors that were significantly correlated with the choroidal structures in consideration of extensive potential 
confounders..
Results
Two hundred and forty consecutive potentially eligible Japanese subjects were invited to participate in the study 
until the number of cases in each group reached 40. Two subjects declined to participate in the study. Of 238 
subjects who agreed to participate in the study, 38 patients were excluded because of the exclusion criteria; 15 
subjects with high myopia, 10 with poor OCT image quality, 5 with macular photocoagulation, 4 with prior vit-
rectomy, 2 with pregnancy, and 2 with severe anemia. In the end, 200 eyes of 200 subjects consisting of 126 men 
and 74 women with a mean (standard deviation) age of 58.6 (12.85) years were studied.
Baseline demographic data. Baseline demographic data are summarized in Supplementary Table S1. 
There were significant differences in several demographic data including the age among the different stages of 
DR. In the group of proliferative DR (PDR) with prior panretinal photocoagulation (PRP), PRPs were performed 
more than 6 months before enrollment in all eyes.
Correlations of choroidal parameters with age, axial length, and sex. The subfoveal choroidal 
thickness (SFCT), total choroidal area (TCA), luminal area, and stromal area were significantly and negatively 
correlated with age and axial length (Supplementary Table S2). The ratio of luminal area to stromal area (L/S 
ratio) was negatively correlated with the axial length. The SFCT, TCA, luminal area, and stromal area were not 
significantly different between sexes without any adjustments, but they were significantly larger in men than in 
women after adjustments for the age and axial length (Supplementary Table S3).
Differences in the choroidal structures at different stages of diabetic retinopathy. The SFCT, 
luminal area, and stromal area were significantly larger in eyes with severe non-proliferative DR (sNPDR) and 
PDR without PRP than those with no diabetic retinopathy (NDR) with and without correction for age and axial 
length (Fig. 1, Table 1, Supplementary Fig. 1). The SFCT, TCA, luminal area, and stromal area in the eyes with 
PDR with prior PRP were significantly smaller than those in the eyes with PDR without PRP with and without 
correction for age and axial length. There was no significant difference in the L/S ratio among the eyes at different 
stages of DR.
correlations between choroidal parameters and continuous variables. The SFCT, TCA, luminal 
area, and stromal area were significantly and positively correlated with the albumin index in the partial regression 
coefficient (Supplementary Table S2). The stromal area was also significantly correlated with the serum level of 
albumin. The L/S ratio was significantly correlated with the best-corrected visual acuity (BCVA) and central 
macular thickness (CMT).
Figure 1. Enhanced depth imaging optical coherence tomographic (EDI-OCT) images and binarized images 
of EDI-OCT acquired from eyes with different stages of diabetic retinopathy. (Top row). EDI-OCT images. 
(Bottom row) binarized EDI-OCT images. Subfoveal choroidal thickness and total choroidal area were 
significantly larger at more advanced stage of DR, and smaller in eyes with PRP than those without. The margins 
of the region of interest are delineated by red lines. Yellow bars indicate the length of 6000 μm. NDR, no diabetic 
retinopathy; mNPDR, mild to moderate nonproliferative diabetic retinopathy; sNPDR, severe NPDR; PDR, 
proliferative diabetic retinopathy; PRP, panretinal photocoagulation.
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Differences in the choroidal structures among groups of different categorical variables. 
Patients were classified as having systemic hypertension when their blood pressure was > 140/90 mmHg, or were 
being treated with anti-hypertensive medications. The TCA and luminal area were significantly smaller in the 
eyes with systemic hypertension than normotensive subjects (Supplementary Table S4). The SFCT, TCA, and 
stromal area in eyes with diabetic macular edema (DME) were larger than those without DME. There were no 
significant differences in the choroidal parameters between using or not using the different types of medications 
for hypertension, hyperglycemia, and dyslipidemia (Supplementary Tables S5 and S6).
Evaluating factors influencing choroidal parameters in multivariate regression analyses. Using 
the variables which were significant in univariate analysis for each choroidal parameter, multivariate regression 
analyses were performed. In multivariate regression analyses, the SFCT was significantly associated with the age, 
axial length, sex, and the stage of DR. The TCA was significantly associated with the age, axial length, sex, albu-
min index, the stage of DR, and hypertension. The luminal area was significantly associated with the age, axial 
length, sex, the stage of DR, and hypertension. The stromal area was significantly associated with the age, axial 
length, albumin index, and the stage of DR. The L/S ratio was significantly correlated with the axial length and 
BCVA. (Table 2).
Discussion
The results showed that the SFCT, TCA, luminal area, and stromal area were significantly associated with the 
age, axial length, and sex in the eyes of diabetic patients with or without DR. These finding are in agreement with 
earlier reports in normal eyes6–8. Importantly, the age and axial length had the strongest correlation with the size 
of the choroidal structures in the multivariate regression analyses. Thus, the choroidal structures in eyes with dia-
betes and DR should be evaluated under strict control of the age and axial length. Unfortunately, as best we know, 
only a few studies have evaluated the choroidal structures in such a manner which may be one of the reasons for 
the contradictory results of the choroidal thickness in DR.
Histopathological studies have shown that a dropout of the choriocapillaris was more extensive in diabetic 
than that in non-diabetic eyes22. Other studies showed that the blood flow of the choriocapillaris was reduced in 
eyes with diabetes and DR26–28, and the degree of reduction increased as the severity of DR progressed27,28. As the 
disease progresses, the increased dropout of choriocapillaris and subsequent hypoxia of retinal pigment epithe-
lium (RPE) and photoreceptors increase the expression of vascular endothelial growth factor (VEGF) from the 
RPE cells29,30 which would lead to a vasodilation of middle and large choroidal vessels. In experimental animals, 
VEGF increased the vessel diameter31, and in human, anti-VEGF therapy decreased the choroidal luminal area in 
eyes with DME and polypoidal choroidal vasculopathy25,32. Pulsatile ocular blood flow which reflects the whole 
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Table 1. Differences in the choroidal structures among the eyes with different stages of diabetic retinopathy. 
NDR, no diabetic retinopathy; mNPDR, mild to moderate nonproliferative diabetic retinopathy; PDR, 
proliferative diabetic retinopathy; PRP, panretinal photocoagulation; SFCT, subfoveal choroidal thickness; SEM, 
standard error of the mean. *One-way analysis of variance. †General linear model where age and axial length 
were used as covariance. Covariates appearing in the model are evaluated at the following values: age = 58.58, 
axial length = 23.86. ‡General linear model where axial length were used as covariance. Covariates appearing in 
the model are evaluated at the following values: axial length = 23.86.








































































































































































































































































Table 2. Multivariate Regression Analysis for the determinants that influenced the choroidal structures*. 
Using the variables which were significant in univariate analysis for each choroidal parameter, multivariate 
regression analyses were performed. Values in bold indicate statistical significance (P < 0.05). SFCT, subfoveal 
choroidal thickness; L/S ratio, ratio of luminal to stromal area; eGFR, estimated glomerular filtration rate; NDR, 
no diabetic retinopathy; mNPDR, mild to moderate nonproliferative diabetic retinopathy; PDR, proliferative 
5Scientific RepoRtS |         (2019) 9:16228  | https://doi.org/10.1038/s41598-019-52750-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
choroidal blood flow was reported to increase as the severity of retinopathy progressed33,34. These findings may 
explain why the luminal area was larger in sNPDR and PDR without PRP than in NDR.
The increase in the vascular permeability caused by increased levels of VEGF induces vascular leakage and 
swelling of the choroidal stroma. Choroidal vascular hyperpermeability and leakage of proteinaceous fluid into 
the choroidal stroma have been reported in the eyes with DR3,23. These changes are compatible with our results 
that the stromal areas in sNPDR and PDR without PRP were larger than that in NDR. Thus, the increase of both 
the luminal and stromal areas with a progression of DR account for the increase in the SFCT and TCA without 
significant changes in the L/S ratio.
The SFCT, TCA, luminal area, and stromal area in eyes with PDR with PRP were smaller than those in the eyes 
with PDR without PRP. Previous studies reported that the choroidal thickness, total choroidal area, luminal area 
as well as the choroidal blood flow were decreased after the PRP10,25,33. It has been reported that the VEGF level 
in ocular fluid in patients with PDR was higher than that in patients with NPDR, and that it was decreased after 
PRP35. These findings suggest that the PRP reduced the expression of VEGF which then led to a reduction of the 
choroidal vessel diameters and vascular permeability resulting in a thinning of the choroid. However, the effects 
of PRP on the choroidal structures remain to be elucidated because other cytokines and inflammatory cells are 
known to be involved in this complicated condition36.
We found no significant association between choroidal parameters and the presence of DME or type of DME 
in multivariate analysis. In several studies that examined the choroidal thickness in eyes with DME and/or PDR, 
subjects included had undergone prior treatment with PRP or anti-VEGF therapy that reduces the choroidal 
thickness. This may be another reason for the contradictory results of the choroidal thickness in DR.
The albumin index was significantly correlated with the choroidal stromal area. The reason for the results 
remains unclear. A possible explanation would be that hypoalbuminemia caused by albuminuria lead to fluid 
accumulation in the stromal tissue in the body including choroidal stroma; however, choroidal stromal area was 
not significantly associated with serum albumin in the multivariate analysis.
Albuminuria is caused by the disruption of the filter barrier in the glomeruli which are comprised of nega-
tively charged barriers of the endothelial cells of the glomerular capillaris and basement membranes, and the size 
barriers of the podocytes37,38. The negatively charged barriers restrict the passage of negatively charged molecules 
such as albumin through the capillary lumens into Bowman’s capsule. Choriocapillaris which has fenestration 
similar to the glomerular capillaries consists of endothelial cells lined with a basement membrane both of which 
are negatively charged and serve as charge barriers39,40. It has been reported that there is a disruption of filtration 
barrier associated with a thickening of the basement membrane and a decrease in anionic sites in the basement 
membrane of the choriocapillaris and the glomeruli in diabetic patients41,42. Histologically, the choroid in diabetic 
choroidopathy and the glomeruli in diabetic nephropathy have the characteristic features in common including 
the thickening of the basement membrane of capillaries associated with the periodic acid–Schiff (PAS)-positive 
materials23,43. PAS-positive nodules in the choroidal stroma were reported to closely resemble those in the mes-
engial matrix of glomeruli (Kimmelstiel-Wilson nodule)23. It might be possible that when the glomerular filter 
barrier is damaged more severely, there is a more extensive breakdown of the charge barrier of choriocapillaris 
which has structural and functional similarity to the glomeruli. The breakdown of the charge barrier of the chori-
ocapillaris would allow large molecules to leak outside the capillaries, resulting in fluid retention in the choroidal 
stroma. This may explain the association between the albuminuria and the choroidal stromal edema.
The TCA and luminal area were significantly smaller in the patients with systemic hypertension than nor-
motensive subjects. Choroidal blood volume measured with laser Doppler Flowmetry has been reported to be 
reduced in patients with systemic hypertension16. In addition, choroidal thickness has also been reported to be 
reduced in patients with systemic hypertension or coronary artery disease17,44. The decrease in the luminal area 
caused by arteriosclerosis or vascular contraction due to systemic hypertension may lead to the decrease in the 
TCA. In contrast, Ahn et al. reported that the choroidal thickness was increased in patients with severe hyperten-
sion (defined as systolic blood pressure > 180 or diastolic blood pressure > 110)18. They assumed that interstitial 
fluid accumulation caused by the increased choroidal permeability due to extremely high blood pressure led to 
the thickening of the choroid. In our study, only 12 (8.7%) of 138 patients with systemic hypertension had such 
extremely high blood pressure. Thus, we considered that the effect of increased choroidal permeability on the 
choroidal thickness or choroidal stroma was not observed.
The L/S ratio was negatively correlated with axial length, which was consistent with previous reports8. It also 
was negatively correlated with BCVA. The reason for the results was not unclear; however, the impact of these 
factors on the L/S ratio was quite small (adjusted R2 = 0.084). Other factors which were not evaluated in this study 
might be associated with the L/S ratio.
There are limitations in this study. First, the evaluations of the cross-sectional images of 6000 μm were prob-
ably not sufficient to assume the structural changes of the entire choroid. Evaluations of three-dimensional vol-
umetric scans may provide more conclusive data. Second, this was a cross-sectional study and was limited in 
evaluating the influence of some variants on the choroid especially the effects of medications for systemic hyper-
tension and hyperglycemia on the choroidal structures. Longitudinal studies are needed in the future. Third, the 
manual delineation of the chorioscleral interface was not completely objective. Lastly, the choroidal structural 
changes observed on the OCT images should be interpreted carefully, because we did not confirm them histolog-
ically. The strength of this study included its prospective design in consideration of extensive potential confound-
ers in treatment-naïve eyes.
diabetic retinopathy; PRP, panretinal photocoagulation; BCVA, best corrected visual acuity; CMT, central 
macular thickness. *Data were presented as B, unstandardized coefficients (β, standardized coefficients) [95% 
CI for B]. †Albumin index = the ratio of urinal albumin to urinal creatinine.
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In conclusion, the subfoveal choroidal thickness, total choroidal area, luminal area, and stromal area in eyes 
with diabetes may increase with the progression of DR but decrease after PRP. The total choroidal area and stro-
mal area were significantly correlated with the degree of albuminuria, suggesting the association between the 
albuminuria and choroidal stromal edema.
Material and Methods
The procedures used in this study conformed to the tenets of the Declaration of Helsinki, and a signed informed 
consent was obtained from each subject. This study was approved by the Institutional Review Boards of Sapporo 
City General Hospital and Tokushima University Hospital.
Inclusion and exclusion criteria. This was a prospective, cross-sectional, interventional study of 200 eyes 
of 200 consecutive patients with type 1 or type 2 diabetes who were examined at Sapporo City General Hospital 
and Tokushima University Hospital between February 2017 and January 2019. During the period, consecutive 
potentially eligible Japanese outpatients with diabetes were invited to participate in the study until the number of 
cases in each group reached 40. The right eye of each patient was included. When the right eyes were excluded by 
the exclusion criteria, the left eyes could be included.
The exclusion criteria included the age of < 20 years or > 80 years, high myopia defined as a spherical equiva-
lent of < −6.0 diopters or an axial length of > 26.5 mm, a BCVA worse than 20/400, ocular hypertension defined 
as intraocular pressure of > 24 mmHg, corneal diseases, glaucoma, and chorioretinal diseases other than DR. Eyes 
with cataract, premacular hemorrhage, and severe macular hard exudates that affected the BCVA and quality of 
EDI-OCT images, poor EDI-OCT image quality defined as an image quality index of < 30, abnormal EDI-OCT 
findings from other chorioretinal diseases than DR were also excluded. Eyes that had been treated with intra-
vitreal injections of anti-VEGF, intravitreal or subtenon injection of steroids, macular photocoagulation, and 
previous intraocular surgeries except for non-complicated cataract surgery also were excluded. Eyes treated with 
any type of previous retinal photocoagulation were excluded except for the eyes with PDR with PRP which were 
performed more than 6 months before enrollment. Patients with other systemic diseases such as heart failure, 
malignancy, endocrine diseases, and severe anemia defined as hemoglobin < 8 g/dl, and subjects under hemodi-
alysis, pregnancy, or steroidal treatment also were excluded.
Systemic and ophthalmic examinations. Systemic examinations performed included systolic and dias-
tolic blood pressure, mean arterial blood pressure (MAP), mean ocular perfusion pressure (MOPP), heart rate, 
hemoglobin, hemoglobin A1C, body mass index, serum level of albumin, triglycerides, total cholesterol, low den-
sity lipoprotein cholesterol, high density lipoprotein cholesterol, creatinine, and estimated glomerular filtration 
rate. MAP and MOPP were calculated according to the following formulas: MAP = diastolic blood pressure + 1/3 
(systolic blood pressure – diastolic blood pressure), and MOPP = 2/3MAP- intraocular pressure. The degree of 
albuminuria was defined as the ratio of urinal albumin to urinal creatinine which was called albumin index. 
Information on the duration of diabetes and current smoking were collected from patients’ oral reports, and 
current medications for systemic hypertension, hyperglycemia, and dyslipidemia also were recorded according 
to the physician’s letter or the medical diaries that were generally used in Japan to record the all medications for 
each patient.
Ophthalmic examinations included measurements of the refractive error, axial length, the BCVA, and 
intraocular pressure, slit-lamp biomicroscopy, indirect ophthalmoscopy, fundus photography, and EDI-OCT. 
Fluorescein angiography was performed according to the ophthalmologists’ decision.
The stage of DR was classified according to the international classification with slight modifications45. We 
classified DR into following 5 groups; NDR, mild to moderate non-proliferative DR, sNPDR, PDR without prior 
photocoagulation, and PDR with prior PRP. DME was defined as increased retinal thickness due to DR with 
CMT ≥ 320 μm for men or ≥ 305 μm for women in a 1 mm diameter circle centered on the fovea, and was classi-
fied into 3 groups; sponge-like retinal swelling, cystoid macular edema, and serous retinal detachment as reported 
(Supplementary Table S1)46. Eyes with retinal swelling caused by epiretinal membrane or vitreomacular traction 
were excluded.
enhanced depth imaging optical coherence tomography. Horizontal and vertical cross-sectional 
EDI-OCT images of 30 degrees that passed through the fovea were obtained by Spectralis OCT instrument 
(Heidelberg Engineering, Heidelberg, Germany) for each eye. Each image was recorded through dilated pupil 
with the eye tracking system, and 100 scans were averaged to enhance the signal-to-noise ratio. The CMT was 
defined as the mean distance between the internal limiting membrane and the outer surface of the RPE in Early 
Treatment of Diabetic Retinopathy Study central subfield of 1mm-diameter. It was automatically measured fol-
lowing a raster scan composed of 31 horizontal B scans covering a 30 × 25 degrees area centered on the fovea.
The examined area of the choroid was 6000 μm wide and was centered on the fovea. The parameters measured 
were the SFCT, TCA, luminal area, and stromal area. The L/S ratio was calculated. The SFCT was defined as the 
distance between the outer border of the RPE and the chorioscleral interface at the center of the fovea, and it was 
measured by two independent investigators (TK and JM) using the caliper function of the software embedded 
in the Spectralis. The average of measurements on the horizontal and vertical scan images was defined as SFCT 
measured by each investigator, and the average of the measurements by two investigators was used for statistical 
analyses.
evaluation of choroidal areas by binarization technique. The EDI-OCT images were evaluated by 
one of the authors (JM) who was masked to the clinical findings. The binarization of the choroidal area in the 
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EDI-OCT images was done by a modified Niblack method using the ImageJ software (ImageJ version 1.47, NIH, 
Bethesda, MD, USA) as described in detail (Fig. 1)24. The examined area was 6000 μm wide and centered on the 
subfoveal choroid from the RPE to the chorioscleral border. In the binarized images, the light and dark pixels 
were defined as the stromal and luminal areas. They were automatically calculated after adding the data on the 
relationship between the distance on the fundus and the pitch of the pixels in the EDI-OCT images, which was 
dependent on the axial length.
All parameters of each horizontal and vertical image were measured three times, and the averages of 6 meas-
urements were used for the statistical analyses. The correlations of the choroidal parameters of EDI-OCT with 
ocular and systemic parameters were determined.
Statistical analyses. The sample size calculation was performed with a statistical software G*Power 3.9.9.2 
(Germany). The effect size of stage of DR on the choroidal thickness was set as 0.25 (medium size effect) accord-
ing to the report by Cohen47 and previous contradictory results1–5. Using a two-sided alpha error of 5% and a 
power of 80%, 40 eyes were required for each of the 5 groups. Other statistical analyses were performed with 
the SPSS version 22 software (IBM, Armonk, New York, USA). The equalities of variances were confirmed with 
the Leven’s tests. The BCVA were converted from decimal visual acuity to the logarithm of the minimum angle 
of resolution for statistical analysis. The significance of the differences in the choroidal parameters between 2 
groups was determined using independent t-tests, and the significances of differences among 3 or more groups 
were determined using one-way analysis of variance and general linear model with the Bonferroni test for post 
hoc analyses. The correlations between choroidal parameters and other continuous variables were determined 
by partial regression coefficients of correlation. Multivariate regression analyses were performed to determine 
the parameters that were significantly correlated with choroidal parameters. The time of day when the EDI-OCT 
images were obtained was evaluated by Kruskal-Wallis analysis9. A two-sided P value of < 0.05 was considered 
statistically significant
Data availability
The dataset generated and analyzed in this study are available from the corresponding author upon reasonable 
request.
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